XORTX Therapeutics (TSXV:XRTX) Tax Rate % : 0.00% (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is XORTX Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. XORTX Therapeutics's Tax Expense for the three months ended in Sep. 2023 was C$0.00 Mil. XORTX Therapeutics's Pre-Tax Income for the three months ended in Sep. 2023 was C$-1.80 Mil. Therefore, XORTX Therapeutics's Tax Rate % for the quarter that ended in Sep. 2023 was 0.00%.

XORTX Therapeutics Tax Rate % Historical Data

The historical data trend for XORTX Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XORTX Therapeutics Tax Rate % Chart

XORTX Therapeutics Annual Data

Trend

Feb15

Feb16

Feb17

Dec18

Dec19

Dec20

Dec21

Dec22

Tax Rate %

Get a 7-Day Free Trial

XORTX Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

XORTX Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

XORTX Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2022 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2022 )	/	Pre-Tax Income (A: Dec. 2022 )
	=	0	/	-9.495
	=	0.00 %

XORTX Therapeutics's Tax Rate % for the quarter that ended in Sep. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Sep. 2023 )	/	Pre-Tax Income (Q: Sep. 2023 )
	=	0	/	-1.804
	=	0.00 %

XORTX Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of XORTX Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

XORTX Therapeutics (TSXV:XRTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XORTX Therapeutics Inc (TSXV:XRTX) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

XRTX:USA ANUA:Germany ANUA:Germany

Address

3710 - 33rd Street NW, Calgary, AB, CAN, T2L 2M1

Website

https://www.xortx.com

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.